The Canadian Journal of Psychiatry
OCLC no. | 04678455 |
---|---|
Links | |
The Canadian Journal of Psychiatry/La revue canadienne de psychiatrie is a monthly
History
The journal was established in January 1956 as The Canadian Psychiatric Association Journal/La revue de l'association canadienne de psychiatrie.[1] The journal started as a quarterly publication, under its founding editor-in-chief, F. Rhodes Chalke.[2] He was succeeded in 1972 by Frederick Lowy, who remained until 1976.[3] Publication changed from bimonthly in 1974 to eight issues a year in 1975. Edward Kingstone took over as editor in 1977.[4] The journal obtained its current name in 1979.[5] He was succeeded in 1995 by Quentin Rae-Grant, who remained until 2004.[6] In 2004, the journal started publishing monthly.[7] Joel Paris became editor-in-chief in October 2004, continuing this role for 10 years.[8] The current editor is Scott Patten, who has been in this role since 2014 [9] The journal published 14 issues per year in 2005 and 2006, but returned to a monthly frequency in 2007.[10] An electronic version of the journal was launched in January 2012. Because of the advertising, web access was restricted to members only in 2012 to avoid direct-to-consumer advertising. Articles had been freely accessible since 2002. In 2013, paid subscribers were also allowed access.[11] As the Journal is now published by SAGE, access is governed by that company's policies. All members of the Canadian Psychiatric Association receive a subscription as a membership benefit.
Abstracting and indexing
The journal is abstracted and indexed in
Online archives
The complete archive of the journal from 1956 to the present is available online. Full-text articles had been freely accessible since 2002. However, in January 2012, online access was restricted for six months, except for members of the Canadian Psychiatric Association who get immediate online access. In 2013, subscribers were allowed immediate online access.
Notable articles
Examples of highly cited articles (>200 times) published in the journal are:[13]
- Seeman, P (2002). "Atypical antipsychotics: Mechanism of action" (PDF). Canadian Journal of Psychiatry. 47 (1): 27–38. S2CID 14930109. This review examined mechanisms of action of the atypical antipsychoticmedications, emphasizing features of their pharmacology relevant to their profile of adverse effects.
- Ghaemi, SN; Ko, JY; Goodwin, FK (2002). "Cade's disease" and beyond: misdiagnosis, antidepressant use, and a proposed definition for bipolar spectrum disorder". Canadian Journal of Psychiatry. 47 (2): 125–134. nosological issues related to bipolar disorder. It also proposed diagnostic criteria for bipolar spectrum disorders, making a unique contribution to the latter topic.
- Taylor, GJ (2000). "Recent developments in alexithymia theory and research". Canadian Journal of Psychiatry. 45 (2): 134–142. PMID 10742872. This review, by one of the developers of the Toronto Alexithymia Scale, examined literature concerned with alexithymia(an inability to identify and describe ones' emotions). The review summarized evidence that alexithymia reflects deficits in the cognitive processing and regulation of emotions. Implications for future research, and for psychotherapy, were identified.
- Newman, SC; Bland, RC (1991). "Mortality in a cohort of patients with schizophrenia: A record linkage study". Canadian Journal of Psychiatry. 36 (4): 239–245. S2CID 12218094. This was a retrospective cohort study that evaluated mortality in a cohort with schizophreniaby linkage to a national mortality registry. A 20-fold increase in the risk of suicide was found, but elevated mortality due to other causes was also identified. Overall, the risk of mortality was doubled and it was estimated that life expectancy was diminished by approximately 20 years.
- Bradwejn, J; Koszycki, D; Meterissian, G (1990). "Cholecystokinin-tetrapeptide induces panic attacks in patients with panic disorder". Canadian Journal of Psychiatry. 35 (1): 83–85. cholecystokinin-tetrapeptide (CCK-4) and placebo were administered to 11 panic disorder patients. CCK-4 (but not placebo) was found to induce panic attackidentical to the spontaneous panic attacks that occur in people with panic disorder.
See also
References
- ^ McKerracher DG. President's foreword. Can. Psychiatr. Assoc. J. 1956; 1(1):1.
- PMID 10696487.
- PMID 1024692.
- .
- ^ Kingstone E. A time for change. Can. J. Psychiatry 1979;24(1):2.
- ^ Rae-Grant Q. Plus ça change, plus c'est la même chose. Can. J. Psychiatry 1995;40(8):433-434.
- PMID 26157865.
- .
- ^ Can. J. Psychiatry 2015;60(1):1-3. The Canadian Journal of Psychiatry in 2014 and beyond. http://publications.cpa-apc.org/media.php?mid=1832. Date accessed March 21, 2016.
- .
- PMID 23327748.
- ^ "Journals Ranked by Impact: Psychiatry". 2020 Journal Citation Reports. Web of Science (Science ed.). Thomson Reuters. 2021.
- Web of Knowledge. Web of Science (Science ed.). Thomson Reuters. 2013.